Association Between Free Fatty Acids and Cardiometabolic Risk in Coronary Artery Disease: Results from the PROMISE Study.
Deshan Yuan,Na Xu,Ying Song,Zheng Zhang,Jingjing Xu,Zhenyu Liu,Xiaofang Tang,Yaling Han,Yan Chen,Yongzhen Zhang,Pei Zhu,Xiaogang Guo,Zhifang Wang,Ru Liu,Qingsheng Wang,Yi Yao,Yingqing Feng,Xueyan Zhao,Jinqing Yuan
DOI: https://doi.org/10.1210/clinem/dgad416
2024-01-01
Abstract:CONTEXT:The association between free fatty acids (FFAs) and unfavorable clinical outcomes has been reported in the general population. However, evidence in the secondary prevention population is relatively scarce.OBJECTIVE:We aimed to examine the relationship between FFA and cardiovascular risk in patients with coronary artery disease (CAD).METHODS:This study was based on a multicenter cohort of patients with CAD enrolled from January 2015 to May 2019. The primary outcome was all-cause death. Secondary outcomes included cardiac death and major adverse cardiovascular events (MACE), a composite of death, myocardial infarction, and unplanned revascularization.RESULTS:During a follow-up of 2 years, there were 468 (3.0%) all-cause deaths, 335 (2.1%) cardiac deaths, and 1279 (8.1%) MACE. Elevated FFA levels were independently associated with increased risks of all-cause death, cardiac death, and MACE (all P < .05). Moreover, When FFA were combined with an original model derived from the Cox regression, there were significant improvements in discrimination and reclassification for prediction of all-cause death (net reclassification improvement [NRI] 0.245, P < .001; integrated discrimination improvement [IDI] 0.004, P = .004), cardiac death (NRI 0.269, P < .001; IDI 0.003, P = .006), and MACE (NRI 0.268, P < .001; IDI 0.004, P < .001). Notably, when stratified by age, we found that the association between FFA with MACE risk appeared to be stronger in patients aged ≥60 years compared with those aged <60 years.CONCLUSION:In patients with CAD, FFAs are associated with all-cause death, cardiac death, and MACE. Combined evaluation of FFAs with other traditional risk factors could help identify high-risk individuals who may require closer monitoring and aggressive treatment.